Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,843 | -7,556 | -4,489 | -2,217 | -10,568 |
| Depreciation Amortization | 771 | 771 | 771 | 193 | N/A |
| Other Working Capital | -857 | 429 | 353 | -19 | 1,455 |
| Other Operating Activity | 682 | -56 | -62 | -69 | 516 |
| Operating Cash Flow | $-9,246 | $-6,411 | $-3,427 | $-2,112 | $-8,597 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,456 | 2,623 | 2,229 | 2,229 | N/A |
| Common Stock Issued | 2,634 | 2,635 | 2,635 | 2,635 | 6,672 |
| Other Financing Activity | 11,691 | 11,691 | -329 | -196 | -693 |
| Financing Cash Flow | $16,781 | $16,950 | $4,535 | $4,668 | $5,979 |
| Beginning Cash Position | 865 | 865 | 865 | 865 | 3,484 |
| End Cash Position | 8,400 | 11,404 | 1,974 | 3,421 | 865 |
| Net Cash Flow | $7,535 | $10,539 | $1,109 | $2,556 | $-2,619 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,246 | -6,411 | -3,427 | -2,112 | -8,597 |
| Free Cash Flow | -9,246 | -6,411 | -3,427 | -2,112 | -8,597 |